Research Paper | Published:

Expression in Yeast of Amino-Terminal Peptide Fusions to Hepatitis B Core Antigen and Their Immunological Properties

Bio/Technologyvolume 8pages644649 (1990) | Download Citation



Hepatitis B core protein (HBcAg) is a potent antigen that gives both a T-cell dependent and a T-cell-independent antibody response. It has been shown that a foreign epitope can be fused to the amino terminus of HBcAg without affecting partide integrity, and that the resulting chimaeric cores retain the immunogenicity of the foreign epitope. Here we describe the efficient expression in yeast of two different chimaeric cores, carrying epitopes of Foot and Mouth Disease Virus (FMDV) or human chorionic gonadotrophin (hCG), which are candidates for FMD and contraceptive vaccines, respectively. These cores could not be produced in E. coli in soluble form but were expressed to high levels in yeast. We constructed a yeast expression vector that allows rapid production of different chimaeric cores by cloning in cassettes encoding foreign epitopes. Both FMDV and hCG-cores were shown to present the epitopes at the sur face of the particles. The FMDV-cores produced in yeast were efficient inducers of neutralising antibodies in guinea-pigs after one low dose.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Stahl, S., Mackay, P., Agazin, M., Bruce, S.A. and Murray, K. 1982. Hepatitis B virus core antigen: synthesis in Escherichia coli and application in diagnosis. Proc. Natl. Acad. Sci. USA. 79: 1606–1610.

  2. 2

    Miyanohara, A., Imamura, T., Araki, M., Sugawara, K., Ohtomo, N. and Matsubara, K. 1986. Expression of hepatitis B virus core antigen gene in Saccharomyces cerevisiae: synthesis of two polypeptides translated from different initiation codons. J. Virol. 59: 176–180.

  3. 3

    Jean-Jean, O., Levrero, M., Will, H., Pericaudet, M. and Rossignol, J.M. 1989. Expression mechanism of the Hepatitis B virus (HBV) C gene and biosynthesis of HBe antigen. Virology 170: 99–106.

  4. 4

    Milich, D.R. and McLachlan, A. 1986. The nucleocapsid of the hepatitis B virus is both a T-cell independent and a T-cell dependent antigen. Science 234: 1398–1401.

  5. 5

    Valenzuela, P., Coit, D., Medina-Selby, M.A., Kuo, C.H., Van Nest, G., Burke, R.L., Bull, P., Urdea, M.S. and Graves, P.V. 1985. Antigen engineering in yeast synthesis and assembly of hybrid hepatitis B surface antigen herpes simplex 1g D particles. Bio/Technology. 3: 323–326.

  6. 6

    Adams, S.E., Dawson, K.M., Gull, K., Kingsman, S.M. and Kingsman, A.J. 1987. The expression of hybrid HIV:Ty virus like particles in yeast. NAture. 329: 68–70.

  7. 7

    Clarke, B.E., Newton, S.E., Carroll, A.R., Francis, M.J., Appleyard, G., Syred, A.D., Highfield, P.E., Rowlands, D.J. and Brown, F. 1987. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature 330: 381–384.

  8. 8

    Clarke, B.E., Brown, A.L., Grace, K.G., Hastings, G.Z., Brown, F., Rowlands, D.J. and Francis, M.J. 1990. Presentation and immunogenicity of viral epitopes on the surface of hybrid hepatitis B virus core particles produced on bacteria. J. Gen. Virol. In press.

  9. 9

    Stevens, V.C. 1986. A synthetic peptide vaccine against human chorionic gonadotrophin. Vaccines. 86. Cold Spring Harbor Laboratory, N.Y.

  10. 10

    Beggs, J.D. 1978. Transformation of yeast by a replicating hybrid plasmid. Nature 275: 104–109.

  11. 11

    Vieira, J. and Messing, J. . 1982. The pUC plasmids, an M13mp7, derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene 19: 259–268.

  12. 12

    Tajima, M., Nogi, Y. and Fukasawa, T. . 1985. Primary structure of the Saccharomyces cerevisiae GAL7 gene. Yeast 1: 67–77.

  13. 13

    Sutton, A. and Broach, J.R. 1985. Signals for transcription initiation and termination in the Saccharomyces cerevisiae plasmid 2μm circle. Mol. Cell. Biol. 5: 2770–2780.

  14. 14

    Strohmaier, K., Franze, R. and Adam, K.-H. 1982. Location and characterisation of the antigenic portion of the FMDV immunising protein. J. Gen. Virol. 59: 295–306.

  15. 15

    Broekhuijsen, M.P., Van Rijn, J.M.M., Blom, A.J.M., Pouwels, P.H., Enger-Volk, B.E., Brown, F. and Francis, M.J. . 1987. Fusion proteins with multiple copies of the major determinant of foot-and-mouth disease virus protect both the natural host and laboratory animals. J. Gen. Virol. 68: 3137–3143.

  16. 16

    Parry, N.R., Ouldridge, E.J., Burnett, P.V., Clarke, B.E., Francis, M.J., Fox, J.D., Rowlands, D.J. and Brown, F. . 1989. Serological prospects for peptide vaccines against food-and-mouth disease virus. J. Gen. Virol. 70:In press.

  17. 17

    Francis, M.J., Fry, C.M., Rowlands, D.J. and Brown, F. 1988. Qualitative and quantitative differences in the immune response to foot-and-mouth disease virus antigens and synthetic peptides. J. Gen. Virol. 69: 2483–2491.

  18. 18

    Imamura, T., Sugahara, K., Adachi, S., Miyatsu, Y., Mizokami, H. and Matsusaka, T. . 1988. Purification and characterisation of the hepatitis B virus core antigen produced in the yeast Saccharomyces cerevisiae . J. Biotechnol. 8: 149–162.

  19. 19

    Kniskern, P.J., Hagopian, A., Montgomery, D.L., Burke, P., Dunn, N.R., Hofmann, K.J., Miller, W.J. and Ellis, R.W. 1986. Unusually high-level expression of a foreign gene (hepatitis B core antigen) in Saccharomyces cerevisiae . Gene 46: 135–141.

  20. 20

    Baker, S.M., Johnston, S.A., Hopper, J.E. and Jaehning, J.A. 1987. Transcription of multiple copies of the yeast GAL7 gene is limited by specific factors in addition to GAL4 . Mol. Gen. Genet. 208: 127–134.

  21. 21

    Hallewell, R.A., Mills, R., Tekamp-Olson, P., Blacher, R., Rosenberg, S., Otting, F., Masairz, F.R. and Scandella, C.S. 1987. Amino terminal acetylation of authentic human Cu, Zn superoxide dismutase. Bio/Technology 5: 363–366.

  22. 22

    Cousens, L.S., Shuster, J.R., Gallegos, C., Ku, L., Stampien, M.M., Urdea, M.S., Sanchez-Pescador, R., Taylor, A., Tekamp-Olson, P. 1987. High level expression of proinsulin in the yeast, Saccharomyces cerevisiae . Gene 61: 265–275.

  23. 23

    Braddock, M., Chambers, A., Wilson, W., Esnouf, M.P., Adams, S.E., Kingsman, A.J. and Kingsman, S.M. 1989. HIV-1 TAT activates presynthesised RNA in the nucleus. Cell 58: 269–279.

  24. 24

    Pereira, H.G. 1978. Antigenic variation in relation to epidemiology and control of foot-and-mouth disease. Brit. Vet. J. 134: 58–62.

  25. 25

    Francis, M.J., Hastings, G.Z., Clarke, B.E., Brown, A.L., Beddell, C.R., Rowlands, D.J. and Brown, F. 1990. Neutralising antibodies to all seven serotypes of foor and mouth disease virus elicited by synthetic peptides. Immunology 69: 171–176.

  26. 26

    Francis, M.J., Clarke, B.E., Hastings, G.Z., Brown, A.L., Rowlands, D.J. and Brown, F. 1990. Immune response to peptide/hepatitis B core antigen fusion proteins. Vaccines '90, Cold Spring Harbor Laboratory, N.Y. In press.

  27. 27

    Zanetti, M., Sercarz, E. and Salk, J. 1987. The immunology of new generation vaccines. Immunology Today 8: 18–25.

  28. 28

    Argos, P. and Fuller, S.D. 1988. A model for hepatitis B virus core protein: prediction of antigenic sites and relationship to RNA virus capsid proteins. EMBO J 7: 819–824.

  29. 29

    Stahl, S.J. and Murray, K. 1989. Immunogenicity of peptide fusions to Hepatitis B virus core antigen. Proc. Nat. Acad. Sci. 86: 6283–6287.

  30. 30

    Milich, D.R., McLachlan, A., Stahl, S., Wingfield, P., Thornton, G.B., Hughes, J.L. and Jones, J.E. 1988. Comparative immunogenicity of hepatitis B virus core and e antigens. J. Immunol. 141: 3617–3624.

  31. 31

    Casadaban, M. and Cohen, S. 1980. Analysis of gene control signals by DNA fusion and cloning in Escherichia coli . J. Mol. Biol. 138: 179–207.

  32. 32

    Sanger, F., Coulson, A.R., Barrell, B.G., Smith, A.J.H. and Roe, B.A. 1980. Cloning in single-standed bacteriophage as an aid to rapid DNA sequencing. J. Mol. Biol. 143: 161–178.

  33. 33

    McLeod, M., Volkert, F. and Broach, J. 1984. Components of the site specific recombination system encoded by the yeast plasmid 2-micron circle. Cold Spring Harbor. Quant. Symp. Biol. 49: 779–787.

  34. 34

    Ito, H., Fukuda, Y., Murata, K. and Kimura, A. 1983. Transformation of intact yeast cell treated with alkali cations. J. Bact. 153: 163–168.

  35. 35

    Sherman, F., Fink, G.R. and Lawrence, C.W. 1983. Methods in Yeast Genetics. Cold Spring Harbor, N.Y.

  36. 36

    Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685.

  37. 37

    Voller, A., Bartlett, A., Blunell, D.E., Clark, M.F. and Adams, A.N. 1976. The detection of virus by enzyme-linked immunosorbent assay (ELISA). J. Gen. Virol. 33: 165–167.

  38. 38

    Francis, M.J. and Black, L. 1983. Antibody response in pig nasal fluid and serum followin foot-and-mouth disease infection or vaccination. J. Hygiene 91: 329–334.

Download references

Author information

Author notes

  1. M.A. Romanos: Corresponding author.


  1. Wellcome Research Laboratories, Langley Court, Beckenham, Kent, BR3 3BS

    • K.M. Beesley
    • , J.J. Clare
    • , F. Brown
    •  & M.A. Romanos
  2. Department of Molecular Biology and Virology, Langley Court, Beckenham, Kent, BR3 3BS

    • M.J. Francis
    •  & B.E. Clarke
  3. Wellcome Biotech, and Microscopy Unit, (Pharmacology), Langley Court, Beckenham, Kent, BR3 3BS

    • J.E. Beesley
    •  & P.J.C. Dopping-Hepenstal


  1. Search for K.M. Beesley in:

  2. Search for M.J. Francis in:

  3. Search for B.E. Clarke in:

  4. Search for J.E. Beesley in:

  5. Search for P.J.C. Dopping-Hepenstal in:

  6. Search for J.J. Clare in:

  7. Search for F. Brown in:

  8. Search for M.A. Romanos in:

About this article

Publication history



Issue Date